Anatomy of the First Septal Perforating Artery: A Study With Implications for Ablation Therapy for Hypertrophic Cardiomyopathy
- 1 August 2001
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 76 (8) , 799-802
- https://doi.org/10.1016/s0025-6196(11)63224-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic CardiomyopathyCirculation, 1999
- Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy: Acute Results and 3-Month Follow-Up in 25 PatientsJournal of the American College of Cardiology, 1998
- Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathyThe Lancet, 1995
- Hypertrophic cardiomyopathyProgress in Cardiovascular Diseases, 1994
- Hypertrophic cardiomyopathyCurrent Problems in Cardiology, 1993
- Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.Circulation, 1992
- The outcome of surgical treatment of hypertrophic obstructive cardiomyopathyThe Journal of Thoracic and Cardiovascular Surgery, 1989
- Current operative treatment of obstructive hypertrophic cardiomyopathy.Circulation, 1988
- Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathyEuropean Heart Journal, 1988
- Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A reviewProgress in Cardiovascular Diseases, 1985